Lawmakers on Wednesday despatched Gov. Ron DeSantis a invoice expressly permitting a brand new drug for youngster epilepsy sufferers that incorporates CBD, a ‘non-euphoric’ chemical from cannabis.

The Governor now has until July 11 to behave on the measure (HB 7107). It impacts a drug often known as Epidiolex, the “first FDA-approved drug that incorporates a purified substance derived from marijuana” and is used to deal with seizures in kids.

The invoice, handed unanimously by each chambers this Session, particularly modifications the drug’s classification in state regulation from a Schedule I substance to Schedule V.

The previous means a “excessive potential for abuse, with no accepted medical use, and excessive potential for habit,” whereas the latter means a “low potential for abuse, an accepted medical use, and a gentle potential for habit,” in keeping with a employees evaluation.

“Hashish and compounds derived from cannabis are listed in Schedule I of each federal and Florida regulation,” it provides. Descheduling the remedy “will forestall an interruption within the provide of the drug to Florida sufferers.”

The maker, GW Prescription drugs, preliminarily estimated the value of its drug – which is roofed by insurance coverage – at about $32,500 a yr.

Cannabidiol ( CBD) and tetrahydrocannabinol (THC) are the key compounds in cannabis vegetation.

The ‘non-euphoric’ CBD is usually extracted from hemp, a type of cannabis and botanical cousin to marijuana, and used for treating ache and relieving irritation. THC is the psychoactive ingredient that causes marijuana’s “excessive.”

The invoice follows a transfer final October by then-Legal professional Normal Pam Bondi, who issued an emergency rule permitting the drug in Florida.

Based on Bondi, as many as 4,000 Florida youngsters may use the drug. It’s used to deal with seizures related to Lennox-Gastaut syndrome, and Dravet syndrome, extreme types of epilepsy that start in early childhood.


Bondi had used her authority “to schedule 133 chemical compounds generally utilized in lethal artificial medicine,” in keeping with her spokesman, Whitney Ray. Her transfer on Epidiolex, he stated final yr, marked the “the primary time she has used her authority to deschedule a drug.”

Barring a veto, the invoice takes impact upon DeSantis’ signature. It was one among 9 despatched to him Wednesday night, among the many final of these from the 2019 Legislative Session. The Governor now has all payments handed this yr on his desk for evaluate.